Thyroxine replacement therapy enhances clearance of chylomicron remnants in patients with hypothyroidism
about
Therapeutic considerations for postprandial dyslipidaemia.Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.Decreased expression of hepatic low-density lipoprotein receptor-related protein 1 in hypothyroidism: a novel mechanism of atherogenic dyslipidemia in hypothyroidism.The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism.
P2860
Thyroxine replacement therapy enhances clearance of chylomicron remnants in patients with hypothyroidism
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Thyroxine replacement therapy ...... n patients with hypothyroidism
@ast
Thyroxine replacement therapy ...... n patients with hypothyroidism
@en
Thyroxine replacement therapy ...... n patients with hypothyroidism
@nl
type
label
Thyroxine replacement therapy ...... n patients with hypothyroidism
@ast
Thyroxine replacement therapy ...... n patients with hypothyroidism
@en
Thyroxine replacement therapy ...... n patients with hypothyroidism
@nl
prefLabel
Thyroxine replacement therapy ...... n patients with hypothyroidism
@ast
Thyroxine replacement therapy ...... n patients with hypothyroidism
@en
Thyroxine replacement therapy ...... n patients with hypothyroidism
@nl
P2093
P356
P1476
Thyroxine replacement therapy ...... n patients with hypothyroidism
@en
P2093
A Rubinstein
I Grosskopf
M Weintraub
Y Trostanesky
P304
P356
10.1210/JCEM.84.7.5812
P407
P577
1999-07-01T00:00:00Z